Status:
COMPLETED
Immunotherapy for Peanut Allergy
Lead Sponsor:
University of North Carolina, Chapel Hill
Conditions:
Allergy
Eligibility:
All Genders
6-35 years
Phase:
NA
Brief Summary
Currently, when a food allergy is diagnosed, the "standard of care" is strict avoidance of the allergic food and ready access to self-injectable epinephrine. Yet, accidental ingestions do occur. Unfor...
Detailed Description
Peanut allergy is one of the most serious of the immediate hypersensitivity reactions to foods in terms of persistence and severity of the reaction and appears to be a growing problem. Allergen-specif...
Eligibility Criteria
Inclusion
- Subjects between 6 and 35 years of age
- Diagnosed with peanut allergy by positive prick skin test, CAP FEIA of 15 Ku/L or greater
- History of significant clinical symptoms within one hour after ingestion of peanuts
- Family's compliance with all study visits
Exclusion
- Subjects with medical history preventing a BDPCFC to peanut
- Subjects unable to cooperate with challenge procedure
- Subjects unable to be reached by telephone for follow-up
- Subjects with a history of severe anaphylaxis to peanut
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00429429
Start Date
April 1 2006
End Date
May 1 2011
Last Update
June 20 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina
Chapel Hill, North Carolina, United States, 27599